[1] Davatzikos C, Resnick SM, Wu X, et al.  Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI[J]. Neuroimage, 2008, 41(4): 1220-1227.   doi: 10.1016/j.neuroimage.2008.03.050
[2] Jack CR Jr, Knopman DS, Jagust WJ, et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade[J]. Lancet Neurol, 2010, 9(1): 119-128.
[3] Dubois B, Feldman HH, Jacova C, et al.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria[J]. Lancet Neurol, 2007, 6(8): 734-746.
[4] Krishnan S, Talley BD, Slavin MJ, et al.  Current status of functional MR imaging, perfusion-weighted imaging, and diffusion-tensor imaging in Alzheimer's disease diagnosis and research[J]. Neuro-imaging Clin N Am, 2005, 15(4): 853-868, xi.
[5] Jack CR Jr, Petersen RC, Xu Y, et al.  Rates of hippocampal atrophy correlate with change in clinical status in aging and AD[J]. Neurology, 2000, 55(4): 484-489.   doi: 10.1212/WNL.55.4.484
[6] Goldszal AF, Davatzikos C, Pham DL, et al.  An image-processing system for qualitative and quantitative volumetric analysis of brain images[J]. J Comput Assist Tomogr, 1998, 22(5): 827-837.
[7] Fein G, Landman B, Tran H, et al.  Statistical parametric mapping of brain morphology: sensitivity is dramatically increased by using brain-extracted images as inputs[J]. Neuro-image, 2006, 30(4): 1187-1195.
[8] Whitwell JL, Jack CR Jr.  Neuroimaging in dementia[J]. Neurol Clin, 2007, 25(3): 843-857.   doi: 10.1016/j.ncl.2007.03.003
[9] Kantarci K, Petersen RC, Przybelski SA, et al.  Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cere brovascular disease in mild cognitive impairment subtypes[J]. Arch Neurol, 2008, 65(12): 1621-1628.
[10] Whitwell JL, Przybelski SA, Weigand SD, et al.  3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease[J]. Brain, 2007, 130(Pt7): 1777-1786.
[11] Broe M, Hodges JR, Schofield E, et al.  Staging disease severity in pathologically confirmed cases of frontotemporal dementia[J]. Neurology, 2003, 60(6): 1005-1011.   doi: 10.1212/01.WNL.0000052685.09194.39
[12] Kitagaki H, Mori E, Yamaji S, et al.  Frontotemporal dementia and Alzheimer disease: evaluation of cortical atrophy with automated hemispheric surface display generated with MR images[J]. Radiology, 1998, 208(2): 431-439.   doi: 10.1148/radiology.208.2.9680572
[13] Laakso MP, Frisoni GB, Könönen M, et al.  Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: a morphometric MRI study[J]. Biol Psychiatry, 2000, 47(12): 1056-1063.   doi: 10.1016/S0006-3223(99)00306-6
[14] No authors listed.  Clinical and neuropathological criteria for frontotemporal dementia.The Lund and Manchester Groups[J]. J Neurol Neurosurg Psychiatry, 1994, 57(4): 416-418.   doi: 10.1136/jnnp.57.4.416
[15] Kenny ER, Burton EJ, O'Brien JT.  A volumetric magnetic resonance imaging study of entorhinal cortex volume in dementia with Lewy bodies.A comparison with Alzheimer's disease and Parkinson's disease with and without dementia[J]. Dement Geriatr Cogn Disord, 2008, 26(3): 218-225.
[16] Kantarci K, Avula R, Senjem ML, et al.  Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI[J]. Neurology, 2010, 74(22): 1814-1821.   doi: 10.1212/WNL.0b013e3181e0f7cf
[17] Klucken J, McLean PJ, Gomez-Tortosa E, et al.  Neuritic alterations and neural system dysfunction in Alzheimer's disease and dementiawith Lewy bodies[J]. Neurochem Res, 2003, 28(11): 1683-1691.   doi: 10.1023/A:1026061021946
[18] Whitwell JL, Weigand SD, Shiung MM, et al.  Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease[J]. Brain, 2007, 130(Pt3): 708-719.
[19] Sanak D, Nosál'V, Horák D, et al.  Impact of diffusion-weighted MRI-measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis[J]. Neuroradiology, 2006, 48(9): 632-639.   doi: 10.1007/s00234-006-0105-0
[20] Kantarci K, Petersen RC, Boeve BF, et al.  DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment[J]. Neurology, 2005, 64(5): 902-904.   doi: 10.1212/01.WNL.0000153076.46126.E9
[21] Fellgiebel A, Müller MJ, Wille P, et al.  Color-coded diffusiontensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment[J]. Neurobiol Aging, 2005, 26(8): 1193-1198.   doi: 10.1016/j.neurobiolaging.2004.11.006
[22] Zhang B, Li M, Sun ZZ, et al.  Evaluation of functional MRI markers in mild cognitive impairment[J]. J Clin Neurosci, 2009, 16(5): 635-641.   doi: 10.1016/j.jocn.2008.07.080
[23] Mayzel-Oreg O, Assaf Y, Gigi A, et al.  High b-value diffusion imaging of dementia: application to vascular dementia and alzheimer disease[J]. JNeurolSci, 2007, 257(1-2): 105-113.
[24] Zhang Y, Schuff N, Du AT, et al.  White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI[J]. Brain, 2009, 132(Pt9): 2579-2592.
[25] Matsuo K, Mizuno T, Yamada K, et al.  Cerebral white matter damage in frontotemporal dementia assessed by diffusion tensor tractography[J]. Neuroradiology, 2008, 50(7): 605-611.   doi: 10.1007/s00234-008-0379-5
[26] Kantarci K, Reynolds G, Petersen RC, et al.  Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T[J]. AJNR Am J Neuroradiol, 2003, 24(5): 843-849.
[27] Norfray JF, Provenzale JM.  Alzheimer's disease: neuropathologic findings and recent advances in imaging[J]. AJR Am J Roentgenol, 2004, 182(1): 3-13.   doi: 10.2214/ajr.182.1.1820003
[28] Kantarci K, Smith GE, Ivnik RJ, et al.  1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease[J]. J Int Neuropsychol Soc, 2002, 8(7): 934-942.
[29] Coulthard E, Firbank M, English P, et al.  Proton magnetic resonance spectroscopy in frontotemporal dementia[J]. J Neurol, 2006, 253(7): 861-868.   doi: 10.1007/s00415-006-0045-y
[30] Ernst T, Chang L, Melchor R, et al.  Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy[J]. Radiology, 1997, 203(3): 829-836.   doi: 10.1148/radiology.203.3.9169712
[31] Kantarci K, Petersen RC, Boeve BF, et al.  1H MR spectroscopy in common dementias[J]. Neurology, 2004, 63(8): 1393-1398.   doi: 10.1212/01.WNL.0000141849.21256.AC
[32] Liu GR, Gao PY, Lin Y, et al.  Brain magnetic resonance elastography on healthy volunteers: a safety study[J]. Acta Radiol, 2009, 50(4): 423-429.   doi: 10.1080/02841850902751681